A $7.5 million philanthropic donation from Dennis Bastas, CEO of DBG Health, will establish a new Health Leadership acad...
The Hunter Medical Research Institute (HMRI) has announced a new partnership with Novartis Australia, formalised through...
The Snow Medical Research Foundation is launching the Snow Vision Accelerator in partnership with the Universi...
Qiagen has announced the official opening of a new data centre in Melbourne, Australia, designed to strengthen its globa...
Smith+Nephew, the global medical technology company, has announced the launch of a comprehensive foot & ankle repair...
Harrison.ai, a leading global healthtech company and developer of artificial intelligence (AI)-powered medical diagnosti...
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimise ...
AdvanCell, a radiopharmaceutical company specialising in targeted alphaherapias, has announced the expansion of the scop...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been releas...
The Australian government has released Cancer Australia's National Framework for Genomics in Cancer Control, marking a s...
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer treatments, has closed an oversubsc...
The Australian Government is investing close to $20 million in funding for researchers to support groundbreaking nationa...
Kazia Therapeutics Limited , an oncology-focused drug development company, has announced the regulatory approval and lau...
Research has shown the potential for artificial intelligence (AI) to assist in the diagnosis of conditions, like endomet...
The Australian Government is investing almost $11 million to build Australian research capacity in climate change and re...
Inventia Life Science, an innovator in 3D cell culture technologies, has announced the launch of RASTRUM Allegro, a...
Vaxxas, an Australia-based clinical-stage biotechnology company commercialising a novel high-density microarray patch (H...
Brisbane-based medtech startup Convergence Medical has secured AU$5 million from global investors, closing out its succe...
